Torsemide | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Torsemide
US Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Torsemide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 21 USDMF, 19 CEP/COS, 1 JDMF, 8 EU WC, 3 KDMF, 13 NDC API, 29 Listed Suppliers, $ API Reference Price

45 API Suppliers
21 USDMF
19 CEP/COS
1 JDMF
8 EU WC
3 KDMF
13 NDC API
29 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

12 Intermediates Suppliers

12 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

213 FDF Dossiers, 48 FDA Orange Book, 122 Europe, 5 Canada, 14 South Africa, 24 Listed Dossiers

213 FDF Dossiers
48 FDA Orange Book
122 Europe
5 Canada
14 South Africa
24 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 4 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 14 BASF, 1 BioSpectra, 1 Clariant, 6 DFE Pharma, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 25 Kerry, 12 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 15 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 Ulanqab Kema New Material, 3 Vasa Pharmachem

4 SPI Pharma
1 DKSH
4 Faran Shimi Pharmaceutical
8 Boai NKY Pharmaceuticals Ltd
12 Gangwal Healthcare
2 Nanjing Well Pharmaceutical
1 Pfanstiehl
1 Alcedo Pharmachem
7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
14 BASF
1 BioSpectra
1 Clariant
6 DFE Pharma
6 Gangwal Chemicals
1 Ideal Cures Pvt Ltd
3 Ingredion Pharma Solutions
25 Kerry
12 Microlex e.U
2 Novo Excipients
4 Pharmatrans-Sanaq
4 Pluviaendo
3 Prachin Chemical
15 Roquette
1 Seppic
4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shanghai Welltone Material Technology Co., Ltd
10 Sigachi Industries
3 Ulanqab Kema New Material
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

70 Fillers, Diluents & Binders, 37 Direct Compression, 31 Disintegrants & Superdisintegrants, 20 Granulation, 18 Co-Processed Excipients, 17 Thickeners and Stabilizers, 13 Lubricants & Glidants, 10 Solubilizers, 8 Controlled & Modified Release, 8 Chewable & Orodispersible Aids, 6 Parenteral, 5 Coating Systems & Additives, 5 Taste Masking, 3 Topical, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 2 Rheology Modifiers, 2 API Stability Enhancers, 1 Surfactant & Foaming Agents

70 Fillers, Diluents & Binders
37 Direct Compression
31 Disintegrants & Superdisintegrants
20 Granulation
18 Co-Processed Excipients
17 Thickeners and Stabilizers
13 Lubricants & Glidants
10 Solubilizers
8 Controlled & Modified Release
8 Chewable & Orodispersible Aids
6 Parenteral
5 Coating Systems & Additives
5 Taste Masking
3 Topical
3 Emulsifying Agents
3 Film Formers & Plasticizers
2 Rheology Modifiers
2 API Stability Enhancers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 5 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 103 Finished Drug Prices

2 US Medicaid Prescriptions
103 Finished Drug Prices

MARKET PLACE

12 APIs, 12 FDF Dossiers, 1 Intermediates

12 APIs
12 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

2 US Patents, 5 Health Canada Patents

2 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 USP, 14 Others

3 EDQM
5 USP
14 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 272 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 2SARFE PHARMS

filter Patent Number Reset all filters

2 All

01 210154963

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 2Y

filter Expiration Date Reset all filters

2 All

01 22033-10-06

Product Main Page

01

SARFE PHARMS

American Pharma Summit

Not Confirmed

SARFE PHARMS

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-10-06

US Patent Number : 10154963

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213218

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

SARFE PHARMS

American Pharma Summit

Not Confirmed

SARFE PHARMS

American Pharma Summit

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-10-06

US Patent Number : 10154963

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213218

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-10-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?